ArticleClinical optometry2024
Pediatric Scleral Lenses: 21-Year Retrospective Review.
Article in Clinical optometry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Retrospective study to review scleral lens outcomes in the pediatric population over a 21-year period, at a single clinical center. Results: A total of 209 pediatric eyes (108 males and 101 females), distributed between 97 right and 112 left eyes, of which 147 eyes had ocular surface disease and 62 eyes had irregular cornea/refractive conditions, were treated with scleral lenses over a 21-year period. The mean age at the time of treatment initiation was 10.6 ± 2.6 years and at the time of the last evaluation recorded was 14.7 ± 4.0 years. One hundred and forty-seven eyes (70%) continued to wear scleral lenses at the time of review, with a mean duration of lens wear of 8.2 ± 4.6 years. Sixteen eyes (8%) discontinued lens wear, and of these, challenges with application and removal were the predominant reason for discontinuation. The lens wearing status of forty-six eyes (22%) was unknown. Mean LogMAR visual acuity at presentation for the entire cohort was 0.93 ± 0.74 and improved to 0.43 ± 0.58, p < 0.05 with scleral lens wear. LogMAR visual acuity at the last evaluation recorded was 0.4 ± 0.6, p < 0.05. The mean initial lens diameter of the full study cohort was 17.7 ± 1.2 mm, with a mean increase of 1.3mm (p = 0.0004) over the study period, to end with a mean final diameter of 18.2 ± 1.5 mm, at the time of the last evaluation recorded. Conclusion: Scleral lenses are a viable option for therapeutic and visual rehabilitation applications in the pediatric population for both ocular surface disease and irregular cornea/refractive conditions. Most eyes continued to wear lenses over a 21-year review period. The mean final lens diameter was 18.2mm, suggesting that larger diameters do not appear to be a deterrent or obstacle for successful long-term outcomes in the pediatric population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.